UI agreement with Tevard Biosciences to advance therapies for genetic forms of epilepsy
Research on faulty genetic material by University of Iowa (UI) Carver College of Medicine professor Christopher Ahern recently was licensed by Tevard Biosciences, a company that is seeking to treat certain forms of epilepsy.